Understanding the genetic basis of parathyroid carcinoma (Q38176824)

30 August 2017

Understanding the genetic basis of parathyroid carcinoma (English)

1 reference

30 August 2017

Anthony J Gill

1

1 reference

30 August 2017

1 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

25

1 reference

30 August 2017

30-34

1 reference

30 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12022-013-9294-3

30 August 2017

0 references

cites work

Trends in the incidence and treatment of parathyroid cancer in the United States.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Parathyroid carcinoma: increasing incidence and changing presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Parathyroid carcinoma.A study of 70 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Diagnosis and treatment of patients with parathyroid carcinoma: An update and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Parathyroid carcinoma in familial hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Histological diagnosis of carcinoma of the parathyroid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-013-9294-3

Primary hyperparathyroidism: a current perspective

21 January 2018

1 reference

12 December 2020

Frequent Large GermlineHRPT2Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism

1 reference

12 December 2020

Clinical review 122: Parathyroid carcinoma

1 reference

12 December 2020

Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias

1 reference

12 December 2020

Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma

1 reference

12 December 2020

Clinical course of metastatic parathyroid cancer

1 reference

12 December 2020

Parathyroid carcinoma: sixteen new cases and suggestions for correct management

1 reference

12 December 2020

HRPT2 mutational analysis of typical sporadic parathyroid adenomas

1 reference

12 December 2020

Familial parathyroid carcinoma

1 reference

12 December 2020

Letter 2: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma (Br J Surg 2007; 94: 566-570)

1 reference

12 December 2020

Familial cancer of the parathyroid glands. Importance of angiography in the diagnosis of regional recurrences. Considerations on 2 cases

1 reference

12 December 2020

Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.

1 reference

12 December 2020

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification

1 reference

12 December 2020

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors

1 reference

12 December 2020

Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas

1 reference

12 December 2020

Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

1 reference

12 December 2020

Localization and surgical resection of metastatic parathyroid carcinoma

1 reference

12 December 2020

Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma

1 reference

12 December 2020

Parathyroid carcinoma in familial hyperparathyroidism

1 reference

12 December 2020

10.1007/S12022-013-9294-3

Identifiers

DOI

1 reference

PubMed ID

24402736

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24402736